Immunoproteasome Animation | KZR-616 Selective Inhibitor
SCIENTIFIC ANIMATION | Investor presentations and activities
This animation for Kezar Life Sciences provides a comprehensive and engaging visual explanation of the normal function, disease state, and mechanism of action (MoA) of KZR-616 so that the appropriate target audiences can clearly understand the science and subsequent beneficial outcomes.
Kezar Life Sciences successfully utilized the complimentary visual toolkit, developing core brand imagery from the animation for investor strategy, creating cohesive visuals, and building a strong brand identity.
The consistent imagery throughout Kezar’s slide decks, handouts, and presentations gives a professional look and feel and ties in key scientific messages from the animation.
The animation was created for use at industry trade shows and conferences, for corporate fundraising events and investor relations.
The video can currently be found on the immunoproteasome section of the Kezar Life Sciences website and visual assets utilized throughout their 2019 Investor Presentation.
Are you interested in seeing how our award-winning medical animation can help you?
Random42 constantly strives to innovate in the medical animation space. Get in touch for a consultation on your next project.
TESTIMONIALS
‘‘Extremely happy, everybody was great on the team. They answered all our questions and made it look easy. The end result is perfect. ’’
Executive Coordinator, Cellectar Biosciences
‘‘The presentation was dramatically enhanced by the video, which looked fantastic on the big screen. Thank you and the entire Random42 team for your excellent work and for getting the final edition to me in time for the conference. All very much appreciated! ’’
President and CEO, Vallum Corporation
‘‘The quality of the work produced by Random42 sets them apart and helps us quickly tell our scientific story more clearly. The high-quality production value is bolstered by their depth of knowledge. Together, that helps us tell the story of a complex disease and cell-based treatment and make it understandable to professionals and laypeople alike.’’
CEO, Brainstorm Cell Therapeutics
‘‘Working with the Random42 team was a seamless collaboration, where they exhibited great project management skills, clear & thoughtful communication, and delivered high-quality work that was visually appealing. Our team was impressed with the final products!’’
Medical Affairs, Phathom Pharmaceuticals
